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A new method to localize active renin in tissues by autoradiography:
Application to dog kidney. A method was developed to localize active
renin in dog kidney sections using autoradiography to detect in vitro
binding of the radiolabeled renin inhibitor, '251-H77. Light fixation by
prior perfusion of the kidney with paraformaldehyde was used to
immobilize renin without denaturing its binding activity. Snap frozen
sections were cut on a cryostat and incubated with '251-H77. Dry film
autoradiography revealed discrete binding of '251-H77 to the vascular
pole of glomerulus as well as diffuse binding to the outer medulla and to
the cortex. Binding of '251-H77 to other aspartyl proteases in the latter
two regions was then suppressed by addition of the aspartyl protease
inhibitor, N-acetyl-pepstatin (I ILM). This revealed only the juxtaglo-
merular binding and successfully suppressed binding of the radioligand
to other sites. Light microscopic emulsion autoradiography revealed
highly selective discrete labelling of the juxtaglomerular apparatus.
Competition for this '251-H77 binding by a series of structurally different
renin inhibitors showed a close correspondence between their reported
inhibitory potency for renin and potency in the binding system. This
strongly suggests that the radioligand binds to the active site of renin
immobilized in the kidney. These results demonstrate a new method to
localize active renin in tissues using in vitro autoradiography and
radioinhibitor binding. The method shows promise for localization and
quantitation of tissue renin in extra renal tissues.
Renin (E.C.3.4.23.15), a rate limiting enzyme in the produc-
tion of angiotensin, plays a critical role in the regulation of
blood pressure, fluid and electrolyte homeostasis. Circulating
angiotensin II causes direct vasoconstriction, aldosterone se-
cretion, facilitation of the sympathetic nervous system and
central nervous reactions.
Whereas circulating angiotensin II is of clearcut physiological
importance, there is compelling evidence for the existence of
components of the renin-angiotensin system in tissues such as
kidney [11, adrenal gland [2], heart [3], blood vessels [4] and
brain [5]. From these findings, the concept has been proposed
that locally synthesized angiotensin II might exert local auto-
crine or paracrine influences on target organ function [6—10]. It
is therefore important to understand the sites, and activity, of
renin in key target organs.
Immunohistochemistry has been used to demonstrate renin
immunoreactivity in several organs [11—14]. However, this
technique does not distinguish between active renin and mac-
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tive renin, and it is always difficult to prove specificity; thus,
development of an alternative method which could detect active
renin would be very useful. We have previously established an
in vitro autoradiographic method utilizing radiolabeled angio-
tensin converting enzyme (ACE) inhibitors ['251]351A [15, 16],
to localize and quantitate tissue ACE. The binding of['251]351A
to rat lung [15] and caudate putamen membranes [16] has been
characterized and shown to display high specificity and high
affinity for ACE. Therefore, in the present study we attempted
to develop an in vitro autoradiographic method to localize
active renin with high sensitivity and specificity, analogous to
our use of radiolabeled ACE inhibitors to localize and quanti-
tate tissue ACE [15, 16]. Autoradiography can offer very high
sensitivity when potent tight-binding inhibitors are radiolabeled
to high specific activity [15], and the anatomical framework of
the tissues can be preserved with this method. In the present
study, the specific renin inhibitor H-77 was chosen since this
compound shows particularly high affinity for dog renin [17],
and the specificity of the binding of '25I-H77 to the dog kidney
was determined by competition experiment with a range of
renin inhibitors and unrelated protease inhibitors.
In the present study, we demonstrated discrete binding of
'251-H77 to the juxtaglomerular apparatus by film and micro-
scopic emulsion autoradiography with effective suppression of
non-specific binding by N-acetyl-pepstatin.
Methods
Tissue preparation
Male mongrel dogs were killed by anaesthetic overdose with
pentobarbital; the kidneys were removed and perfused with ice
cold saline followed by 1% paraformaldehyde in 0.1 M sodium
phosphate buffer, pH 7.4, via the renal artery. The kidneys
were then cut into blocks (2 x 2 x 1 cm) and then soaked in 4%
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4,
containing 10% sucrose overnight at 4°C. After fixation, the
blocks were immersed in isopentane-dry ice mixture at —40°C,
and then stored at —70°C. Serial sections of 20 tim-thickness,
were cut on cryostat at —20°C, and thaw-mounted onto gelatin-
alum coated slides. The sections were dried in vacuum desic-
cator overnight with silica gel. For emulsion autoradiography,
serial sections of 10 tim-thickness were used to enable resolu-
tion at the microscopic level.
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Radioligand preparation
The renin inhibitor, H77 (H-dHis-Pro-Phe-His-Leu-Leu-Val-
Tyr-OH), was radioiodinated using immobilized lactoperoxi-
dase (Enzymo-beads, Biorad, Richmond, California, USA).
Briefly, H77 (200 nmoles in 100 sl of 0.01 M HC1) was reacted
with 2 mCi of Na'251 (Amersham International, Buckingham-
shire, England, UK), immobilized lactoperoxidase (100 sg in
100 l distilled Water) and glucose (500 sg in 50 d 100 mM
sodium phosphate buffer, pH 7.4) for two hours at room
temperature. There was a 200-fold molar excess of 1177 in order
to favor production of the mono-iodo derivative. Following
reaction, the mixture was passed through a Sepak C,8 cartridge
(Water Associates, Milford, Massachusetts, USA) to remove
unreacted iodide, which was eluted with 0.05% trifluoroacetic
acid (TFA) (Pierce Chemical Co., Rockford, Illinois, USA).
The radio-iodinated peptide was eluted with 75% acetonitrile in
0.05% TFA, and the volume reduced by evaporation and
injected onto a C18 column of an HPLC (Water Associates) and
eluted isocratically with 24% acetonitrile in triethylamine phos-
phate, pH 3.0. Following HPLC purification, the radioligand
was completely separated from the native peptide. Based on
recovery of H77, specific activity was >1500 Ci!mmol. The
radioligand was stored at —20°C for a maximum eight to nine
weeks.
Radioligand binding to tissue sections
The sections were preincubated in 10 mM sodium phosphate
buffer, pH 7.4, containing 150 ms'i NaCI, 0.2% bovine serum
albumin for 15 minutes at 20°C. Incubation was then performed
for 60 minutes at 20°C in fresh buffer containing 0.5 pCi/mI of
'251-H77 (—330 pM) and 0.1% Triton X-100. Nonspecific binding
was measured in parallel incubations in the presence of 1 M
unlabeled 1177. To inhibit binding to other aspartyl proteases,
the nonspecific aspartyl protease inhibitor, N-acetyl-pepstatin
(1 LM) was added to the incubations. After incubation, the
sections were transferred through four successive, one minute
washes of ice-cold buffer without bovine serum albumin, to
remove nonspecifically bound radioligand. The sections were
then dried under a stream of cold air, loaded into X-ray
cassettes and apposed to Afgascopix CR3B X-ray film (Afga
Gevaert, Belgium) at room temperature for 10 to 14 days.
Dryfilm quantitative autoradiography
After exposure the X-ray films were processed in a Kodak
Rpx-omat automatic developer and the optical density was
quantitated using an MCID image analysis system (Imaging
Research Inc., Ontario, Canada) running on an IBM AT com-
puter. In each cassette, a set of '251-radioactivity standards was
included. These were prepared by applying known amounts of
'251-radioactivity to 5 mm-diameter disks of 20 1km-thick brain
or kidney sections mounted on gelatin-alum coated slides. The
radioactivity of the standards were fitted calibration curves by
the computer in order to convert optical density values of each
pixel on the autoradiographs into dpm of '251-radioligand/mm2.
Emulsion autoradiography
For emulsion autoradiography, slide-mounted sections, after
radioligand incubation, were fixed by immersion in 5% glutar-
aldehyde, 2% paraformaldehyde in sodium phosphate buffer,
pH 7.4, for one hour at 4°C. The sections were then taken
through graded ethanol, xylene, rehydrated and air dried, The
sections were then dipped into LM-l liquid nuclear emulsion
(Amersham International) and dried overnight in a humidified
box at 28°C and 98% humidity. They were then exposed for two
weeks in light-tight cassettes with silica gel. After exposure, the
sections were developed with Kodak D19 developer for four
minutes at 17°C, dried and counterstained with hematoxylin and
eosin for a histological examination.
Radioligand binding specificity
The specificity of '251-H77 binding was assessed by compe-
tition experiments using slide-mounted dog kidney sections
with unlabeled renin inhibitors, and unrelated protease inhibi-
tors. For this purpose, N-acetyl-pepstatin, H77, and the other
specific renin inhibitors, SR42128, SR43845, CGP29287,
KR11314, and unrelated inhibitors, enalaprilat (Merck Institute
for Therapeutic Research, West Point, Pennsylvania, USA),
bestatin (Sigma Chemical Co., St. Louis, Missouri, USA) were
added in the concentration range of 10b0 M to 10 M. The
incubation medium contained 0.5 pCi/ml of '251-H77 as in the
routine experiments. The sections were processed as outlined
above, and the autoradiographs were quantitated by computer
densitometry.
Effect of I-H77 on dog plasma renin activity
To evaluate if the inhibitory activity of H77 on renin was
altered after radio-iodination, the effect of iodinated H77 on dog
plasma renin activity was compared with that of H77 in a renin
enzymatic assay. The renin inhibitor, 1177, was iodinated with
nonradioactive 1271 by the procedure used for radio-iodination,
except that Nal was used instead of Na'25!. The elution pattern
of HPLC purification of the products was followed by UV
absorbance at 228 nm and was identical to that observed after
radio-iodination of H77. Similar fractions were collected as
radioligand preparation, evaporated and dissolved in 1 ml of
renin assay buffer which consists of 0.16 M sodium phosphate
buffer, pH 5.5, with 5 mM EDTA-2Na, 4 m phenylmethylsul-
fonylfluoride, 0.2 mivi diisopropylfluorophosphate. The concen-
tration of 1-1177 was determined based on UV absorbance at 228
nm of native 1177. To examine the inhibitory effect of iodinated
1177 (1-1177) in the enzymatic assay, 500 pi of normal dog
plasma was incubated with 500 1d of assay buffer at 37°C for 60
minutes. A range of I-H77 (2.5 >< 10—8 M to 6.3 x l0— M) and
unlabelled H77 concentrations (2.0 X 10'° M to 2.0 X l0 M)
were added into incubations. Angiotensin I generated during
incubation was determined by radio-immunoassay El 81.
Effect of trypsin activation on '251-H77 binding
To assess whether our in vitro autoradiographic method is
sensitive to the proportions of active and inactive renin, 125I.
H77 binding to the dog kidney was examined following trypsin
activation. This procedure is known to convert inactive prore-
nm to renin in many tissues. A series of slide mounted sections
of frozen dog kidney were preincubated in sodium phosphate
buffer in the presence of various concentrations of trypsin (from
50 tg/ml to 5 mg/ml) at 22°C for 15 minutes, and were processed
by the in vitro autoradiographic protocol as described earlier.
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Results
Radioligand preparation
On HPLC analysis a major peak of radiolabeled product was
found at 40 minutes. This peak was well resolved from unla-
beled H77 (Fig. 1) and had a specific activity >1,500 Ci/mmol.
Binding of '251-H77 in dog kidney and effect of N-acetyl-
pepstatin on '251-H77 binding
As shown in Figure 2A, three types of binding pattern of
'251H77 in dog kidney sections were observed. First, punctate
dense binding occurs in the cortex. Second, there is a back-
ground of moderate binding throughout the cortex. Third, there
is moderately high binding in the outer medulla. In the presence
of 1 sM of unlabeled H77, all of these patterns were abolished
and less than 10% of the total binding persisted (Fig. 2B).
Microscopic comparison of the stained sections and film auto-
radiographs revealed that the dense puncta in the cortex closely
corresponded to the vascular pole of glomeruli.
To evaluate the specificity of '251-H77 binding to the dog
kidney, the non-specific aspartyl protease inhibitor, N-acetyl-
pepstatin, was employed. This compound has high affinity for
proteases such as cathepsin D (IC50 9.3 nM) but is a very weak
inhibitor of dog renin (IC50 2.5 M) [19, 20]. In the presence of
1 tM of N-acetyl-pepstatin, only the punctate binding in cortex
was preserved (Fig. 2C). These binding sites are also inhibited
by 1 jiM of H77 (Figs. 2 C and D).
Dose response curves of N-acetyl-pepstatin competing for
'251-H77 binding in anatomically defined regions were gener-
ated. As shown in Figure 3A, N-acetyl-pepstatin had no effect
on '251-H77 binding to the juxtaglomerular region in concentra-
tion up to 1 jiM, and 10 jiM of N-acetyl-pepstatin exhibited a
25% inhibition. By contrast, the binding in both the outer
medulla and the diffuse binding in the cortex were markedly
inhibited by low concentrations of N-acetyl-pepstatin and com-
pletely inhibited by 1 jiM N-acetyl-pepstatin (Figs. 2C, 3B, 3C).
These results suggest that binding of '251-H77 to renin could be
distinguished from background labelling of other aspartyl pro-
teases by including 1 jiM of N-acetyl-pepstatin in the incubation
medium. Therefore, all subsequent binding studies were carried
out in the presence of 1 jiM of N-acetyl-pepstatin.
Emulsion autoradiography
To clarify the localization of the discrete binding found near
glomeruli on film autoradiography, we carried out emulsion
autoradiography. Very high densities of silver grains were
sharply localized to the vascular pole of the glomerulus in the
juxtaglomerular apparatus, including the afferent and efferent
arterioles (Fig. 4A and C). This binding over juxtaglomerular
apparatus was abolished in the presence of 1 jiM of unlabelled
H77 (Fig. 4B and D).
Specificity of radioligand binding: Competition with unlabeled
inhibitors
The specificity of '251-H77 binding to the juxtaglomerular
region was determined by competition studies with a series of
structurally different renin inhibitors and unrelated enzyme
inhibitors.
Figure 5 shows competition curves derived from computer-
ized densitometry of dry film autoradiographs of juxtaglomeru-
lar regions from serial sections exposed to a range of concen-
trations of unlabeled renin inhibitors. Unlabeled SR43845 and
H77 were the most potent inhibitor (IC50 26 n and 41 nM).
SR42128 and KR11314 were less active, and CGP29287 was the
weakest (Table 1).
The potency values of these compounds in competing for
'251H77 binding are in good agreement with the reported IC50
values for enzymatic inhibition of dog renin [17, 21—23] (r =
0.98) or hog renin [241 (Table 1). The angiotensin converting
enzyme inhibitor, enalaprilat or the aminopeptidase inhibitor,
bestatin did not show any inhibition of binding up to 10 jiM.
Effect of I-H77 on dog plasma renin activity
The inhibitory potencies of iodinated and native H77 are
illustrated in Figure 6. I-H77 inhibited dog PRA in a dose-
dependent manner with an IC50 of 3.1 X iO M, which was
close to that of native H77 (IC50: 6.3 x 10—8 M).
Effect of trypsin activation on '251-H77 binding
As shown in Figure 7, preincubation of dog kidney sections
with various concentrations of trypsin resulted in a biphasic
effect on '25I-H77 binding (P < 0.05, ANOVA). Binding was
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Fig. 1. C,8 reverse-phase HPLC elution
profile of H77 radioiodination products
showing the UV absorption profile at 214 nm
(0) and radioactivity (•) in one ml fractions.
The elution position of unlabelled H77 is
shown by the arrow. The fractions pooled for
use as radioligand are shown by the horizontal
bar.
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Fig. 2. Autoradiographs showing '251-H77 binding to dog kidney section. (A) Shows total binding; (B) shows non-specific binding in the presence
of I M ofunlabelled H77; (C) is total binding in the presence of I M N-acetyl-pepstatin, a non-specific aspartyl protease inhibitor; (D) shows the
non-specific binding in the presence of both I /LM of unlabelled H77 and 1 M of N-acetyl-pepstatin. C = cortex; OM == Outer medulla; IM = inner
medulla. Specific binding is indicated by silver grains on a dark background.
enhanced by 35% at 500 g/ml trypsin, and inhibited at higher
trypsin concentrations (>1 mg/mI).
Discussion
H77 (D-His-Pro-Phe-His-Leu-Leu-Val-Tyr-OH) is a potent
inhibitor of dog renin (IC50 = 24 nM). It is an octapeptide analog
of angiotensinogen containing a reduced bond instead of the
peptide linkage at the Leu'°-Leu", This modification at the
cleavage site results in greatly increased binding affinity, and
resistance to cleavage by renin [17].
In this study, '251-labeled H77 was evaluated as a radioligand
to detect active renin in tissue sections, analogous to our use of
radiolabeled angiotensin-converting enzyme inhibitors to label
tissue angiotensin converting enzyme [15, 161. In developing
this method for autoradiographic localization of renin, there are
severe potential difficulties. First, it is not known whether
'251H77 after iodination is still an active renin inhibitor. The
inhibitory potency of the ligand on dog plasma renin activity
(PRA) was therefore examined in experiments with non-radio-
actively iodinated renin inhibitor, I-H77. In the renin enzymatic
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Inhibitor, M
Fig. 3. Binding isotherms demonstrating competition of'251-H77 bind-
ing in anatomically defined regions of the dog kidney by unlabelled H77(0) and N-acetyl-pepstatin (•). Panel A shows binding to the juxtaglo-
merular regions and panel B is binding to the outer medulla, while panel
C is binding to the cortical regions between glomeruli. Specific binding
(B) is expressed as a percentage of that in the absence of competing
ligand (B0).
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00
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100 problem was solved by fixing the tissues by perfusion with 1%
paraformaldehyde solution followed by post-fixation of small
80 blocks of tissue in 4% paraformaldehyde. Third is the potential
labelling of other aspartyl proteases by '251-H77. Szelke et at
60 - measured the inhibitory effect of H77 on acid protease activityin human kidney extract by the release of tritium-labeled
peptides from hemoglobin [171. Although they reported that
40 1177 was a much weaker inhibitor of human kidney acid
proteases than of renin, the kidney contains very high concen-
trations of aspartyl proteases other than renin, which might
interfere with this method.
I
In the current study, '251-H77 was observed to bind to both
io—° io- io- 10-i b-6 b-5 -io-4 cortex and outer medulla in addition to the juxtaglomerular
region. In contrast, renin is localized predominantly to the
100 -.
—
juxtaglomerular apparatus [25] with low concentrations de-
B tected in proximal tubule [26]. The pattern of binding observed
80 •\\ suggested that '251-H77 was binding to another enzyme(s) as
well as renin. One major enzyme which could interfere is
cathepsin D (E.C.3.4.23.5) which occurs in the distal convo-
60 luted tubule and ascending limb of the loop of Henle [27]. Thus,
q\ \, binding in the outer medulla might represent cathepsin D in the
40 \ \ ascending limb of Henle.\ \ N-acetyl-pepstatin is a potent inhibitor of aspartyl proteases.
20 \ Its IC50 value for cathepsin D is 9.3 n but it is a very weak
renin inhibitor with an IC50 of only 2.5 M [19, 20]. We
therefore attempted to differentiate renin from other aspartyl
QQ -9 10-8 -7 1 --- proteases by using N-acetyl-pepstatin. As shown in Figure 2C,1 iM of N-acetyl-pepstatin had no effect on 1251-H77 binding to
juxtaglomerular regions. On the other hand, the inhibitory
100- potency of N-acetyl-pepstatin on binding to the intervening
cortex and outer medulla was similar to H77. This finding was
80- confirmed by competition studies of H77 and N-acetyl-pepsta-
tin on '251-H77 binding. The pattern of inhibitory action of H77
60 is quite different from that of N-acetyl-pepstatin. The most
striking difference is on binding to juxtaglomerular region (Fig.
3A) where H77 is approximately 1000-fold more potent than
40 N-acetyl-pepstatin. One micromolar of N-acetyl-pepstatin in-
hibited the binding only by 3% in this region. These results
20 reveal that '251-H77 binding to the juxtaglomerular region is
preserved preferentially by use of N-acetyl-pepstatin.
________________________________________
Liquid emulsion autoradiography was used to prove a more
1 0-° 1 O- 1 0 1 b- 1-6 10-s 1 detailed localization of 1251-H77 binding; this revealed discrete
binding at the vascular pole of the glomerulus.
The potency of renin inhibitors in competing for radioligand
bindings closely parallels their activity as anticatalytic inhibi-
tion of renin (Table 1). No inhibitory effect was observed by
unrelated enzyme inhibitors such as enalaprilat and bestatin.
These findings suggest that '251-H77 specifically labels the
catalytic site of renin in the kidney sections and indicate it does
not appreciably label aspartyl protease other than renin when
incubations are performed in the presence of 1 rM unlabeled
N-acetyl-pepstatin.
To demonstrate that the in vitro autoradiographic procedure
can detect alteration of the proportion of active and inactive
renin in the dog kidney, experiments were performed using
trypsin activation. It is well documented that prorenin can be
activated by acidification, cold, and proteases, such as trypsin
[28]. All incubations in the present study were therefore per-
formed at neutral pH and at room temperature, where these
assay, 1-1177 effectively inhibited dog PRA and its potency was
found to be in the same order of potency as unlabeled H77 (Fig.
6). This demonstrates that iodination does not significantly
affect the biological activity of H77. Second, the renin content
is very low, even in the major site of production, the kidney,
and renin in glomerular cells is not membrane bound and it is
readily liberated from tissues during freezing and thawing. This
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Fig. 4. Light microscopic emulsion autoradiography showing detection of active renin labelling in the juxtaglomerular apparatus. (B) and (D)
show nonspecific binding. Magnification (A) and (B): x 75, (C) and (D), X 200. Silver grains appear as dark brown indicated by the arrows. Sections
were counterstained with haematoxylin eosin.
factors would have minimal effect on the content of active
renin. Trypsin activation increased binding of '251-H77 by 35%,
with reversal of the effect at higher trypsin concentrations (Fig.
7). This effect is compatible with other rcnin activity studies
using different techniques t281, and suggests that the in vitro
autoradiographic method does not materially affect the ratio of
active and inactive renin.
In conclusion, we have established a method for autoradio-
graphic localization of active renin. This technique provides a
promising method for the quantitative localization of active
renin in other tissues and should be able to be extended to other
species using other radiolabeled renin inhibitors.
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